Differential detection of actionable alterations across CGP panels in biliary tract cancer: implications for panel selection.
Different genomic testing panels detect different cancer mutations, suggesting doctors should choose tests based on tumor type and tissue source for better results.
This nationwide database comparative study examined differences in actionable alteration detection across comprehensive genomic profiling panels. Actionable alteration yield differed across tissue and liquid panels, supporting context-specific panel selection.
What the study was
- Study design
- Nationwide database comparative study
- Population
- 8840 patients with biliary tract cancer
- Sample size
- 8840
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- International journal of clinical oncology
Why it surfaced
Retained as a standard-priority nationwide database comparative study after PubMed abstract review; the score reflects clinical relevance, design strength, novelty, and population need under the v1.3 conservative rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.